Richard James Gregory
Independent Non-Executive DirectorDr. Richard James Gregory, also known as Rich, is Chairman of Scientific Advisory Board of Mitotherapeutix, LLC. Dr. Richard James Gregory, also known as Rich, Ph.D., M.D., serves as Independent Non-Executive Director in April 2020. He was an Independent Director of Homology Medicines, Inc. since 2015 until June 2023. He serves as an Independent Non-Executive Director at CANbridge Life Sciences Ltd. since April 2020. He has served on the Board of Directors of Cambridge Therapeutic Technologies since 2015 and March 2021, respectively. Dr. Gregory has been Independent Non-Executive Director at CANbridge Pharmaceuticals Inc. since April 2020. Dr. Gregory served as an independent non-employee Director of Homology Medicines since 2015. Dr. Gregory served as the Chief Scientific Officer of ImmunoGen, Inc. since January 5, 2015 until August 2019 and served as its Executive Vice President since September 9, 2015 until August 30, 2019. Dr. Gregory provided leadership and direction to the research organization and was responsible for the generation of development candidates based upon ImmunoGen's Antibody Drug Conjugate technology. Dr. Gregory has extensive scientific and research management experience, most of it gained in positions of increasing responsibility at Genzyme. Dr. Gregory served as the Head of R & D Center at Genzyme Therapeutic Products Limited Partnership. He served as an Executive Vice President of Research at ImmunoGen, Inc. from January 5, 2015 to September 9, 2015. He served as a Senior Vice President and Head of Research for the Sanofi Genzyme Research & Development Center from 2011 through 2014. He served as a Head of the Sanofi-Genzyme R&D Center and in that capacity was responsible for Genzyme R&D from discovery through regulatory approval since 2011. Dr. Gregory served as a Senior Vice President at Genzyme Corporation and Head of Research since 2003 until Genzyme Corporation’s acquisition by Sanofi in 2011, responsible for Discovery and Pre-Clinical Research across all technology platforms and medical areas. He also served as a Vice President of Research at Genzyme Corporation since 2003. Dr. Gregory was responsible for oversight of pre-clinical research conducted at Genzyme. In 1989, Dr. Gregory joined Genzyme Corporation, where he was responsible for several discovery projects in the molecular biology department. Research on the molecular basis of cystic fibrosis led to the development of Genzyme's CF gene therapy program, for which Dr. Gregory served as Project Team Leader until 1993. From 1993 to 1995, Dr. Gregory served as Director of Molecular Biology at Canji, Inc. in San Diego, where he conducted research on development of gene therapies for cancer. Dr. Gregory returned to Genzyme in 1995 to Head the gene therapy program as Vice President for Gene Therapy. He serves as a Director at MG Biotherapeutics LLC. He had been Director of ProMIS Neurosciences Inc. since October 12, 2016 until June 29, 2023. He serves as a Member of Scientific Advisory Board at Permeon Biologics, Inc. Dr. Gregory served as a Member of Scientific Advisory Board at RheoGene, Inc. Dr. Gregory is a Fellow of the American Institute for Medical and Biological Engineering. He is the co-author of over 60 peer-reviewed publications and 23 issued U.S. patents in the area of biotechnology. Dr. Gregory received the Genzyme President's award for this work in 1991. Dr. Gregory is the co-author of over 60 peer-reviewed publications. Dr. Gregory is a Member of Scientific Advisory Board at Mythic Therapeutics, Inc. Dr. Gregory received his Ph.D. in Biochemistry from the University of Massachusetts at Amherst in 1986, followed by post-doctoral research in cancer genetics at the Worcester Foundation for Experimental Biology in Shrewsbury MA and bachelor’s degree in Science in Biochemistry from Virginia Polytechnic Institute and State University in June 1980.
Positions
- Company NameCANbridge Pharmaceuticals Inc.Stock Code01228PositionIndependent Non-Executive DirectorColleagues
- QXQun XueFounder, Chairman of the Board, CEO & Member of Strategic Advisory Board
- LZLillian ZhangSenior Director & Head of Finance Operations and Controller
- JSJoe ShenChief Operating Officer
- QMQian MaVice President, Company Secretary & General Counsel
- CCChris ChenSenior Vice President of Human Resources
- PKPeng Kuan ChanIndependent Non-Executive Director
- JAJames Arthur GeraghtyIndependent Non-Executive Director
- MAMark Alan GoldbergMember of Strategic Advisory Board
